National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Lip and Oral Cavity Cancer Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 08/19/2009



General Information About Lip and Oral Cavity Cancer






Stages of Lip and Oral Cavity Cancer






Recurrent Lip and Oral Cavity Cancer






Treatment Option Overview






Treatment Options by Stage







Treatment Options for Recurrent Lip and Oral Cavity Cancer






To Learn More About Lip and Oral Cavity Cancer






Get More Information From NCI






Changes to This Summary (08/19/2009)






About PDQ



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Treatment Options for Recurrent Lip and Oral Cavity Cancer

Treatment of recurrent lip and oral cavity cancer may include the following:

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with recurrent lip and oral cavity cancer. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov